Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Bruni

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 15, 2010
Post-operative radiotherapy in N2 non-small cell lung cancer: a retrospective analysis of 175 patientsVieri Scotti, Icro Meattini, Calogero Saieva, et al.
Tumori|October 12, 2012
Vinorelbine-based chemo-radiotherapy in non-small cell lung cancerVieri Scotti, Calogero Saieva, Vanessa Di Cataldo, et al.
Clinical Lung Cancer|November 1, 2025
Clinical Outcomes and Predictive Factors in NSCLC after Surgery: Findings from the RAC-TAC StudyAlessio Bruni, Davide Franceschini, Beatrice Marini, et al.
Clinical Breast Cancer|March 26, 2018
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control StudyIcro Meattini, Donato Pezzulla, Calogero Saieva, et al.
La Radiologia Medica|August 31, 2024
Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC studyValerio Nardone, Alessio Bruni, Davide Franceschini, et al.
Frontiers in Oncology|February 15, 2024
Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysisPatrizia Ciammella, Salvatore Cozzi, Paolo Borghetti, et al.
Medical Oncology (Northwood, London, England)|December 29, 2023
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative "triplet" for oligometastatic hormone sensitive prostate cancer patientsGiulio Francolini, Angelo Porreca, Gaetano Facchini, et al.
Biomolecules|March 28, 2026
Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot StudyGiorgio Facheris, Alessio Bruni, Valerio Nardone, et al.
Journal of Neuro-Oncology|May 5, 2019
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trialSara Pedretti, Laura Masini, Enrico Turco, et al.
Cancers|April 3, 2021
Impact of Gastrointestinal Side Effects on Patients' Reported Quality of Life Trajectories after Radiotherapy for Prostate Cancer: Data from the Prospective, Observational Pros-IT CNR StudyMarianna Noale, Alessio Bruni, Luca Triggiani, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 15, 2010
Post-operative radiotherapy in N2 non-small cell lung cancer: a retrospective analysis of 175 patientsVieri Scotti, Icro Meattini, Calogero Saieva, et al.
Tumori|October 12, 2012
Vinorelbine-based chemo-radiotherapy in non-small cell lung cancerVieri Scotti, Calogero Saieva, Vanessa Di Cataldo, et al.
Clinical Lung Cancer|November 1, 2025
Clinical Outcomes and Predictive Factors in NSCLC after Surgery: Findings from the RAC-TAC StudyAlessio Bruni, Davide Franceschini, Beatrice Marini, et al.
Clinical Breast Cancer|March 26, 2018
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control StudyIcro Meattini, Donato Pezzulla, Calogero Saieva, et al.
La Radiologia Medica|August 31, 2024
Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC studyValerio Nardone, Alessio Bruni, Davide Franceschini, et al.
Frontiers in Oncology|February 15, 2024
Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysisPatrizia Ciammella, Salvatore Cozzi, Paolo Borghetti, et al.
Medical Oncology (Northwood, London, England)|December 29, 2023
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative "triplet" for oligometastatic hormone sensitive prostate cancer patientsGiulio Francolini, Angelo Porreca, Gaetano Facchini, et al.
Biomolecules|March 28, 2026
Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot StudyGiorgio Facheris, Alessio Bruni, Valerio Nardone, et al.
Journal of Neuro-Oncology|May 5, 2019
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trialSara Pedretti, Laura Masini, Enrico Turco, et al.
Cancers|April 3, 2021
Impact of Gastrointestinal Side Effects on Patients' Reported Quality of Life Trajectories after Radiotherapy for Prostate Cancer: Data from the Prospective, Observational Pros-IT CNR StudyMarianna Noale, Alessio Bruni, Luca Triggiani, et al.
Pageof 8